Kit ELISA Endoglin sandwich (human): quantitative determination of Hu Endoglin in serum, plasma, a buffered solution or cell culture medium. The test recognizes only the natural and recombinant forms of Hu endoglin.
Kit ELISA Endoglin sandwich (human): quantitative determination of Hu Endoglin in serum, plasma, a buffered solution or cell culture medium. The test recognizes only the natural and recombinant forms of Hu endoglin.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
CD105 (l-endogline is a type I transmembrane protein) is strongly expressed on human vascular endothelial cells and is present on an O- and N-glycosylated homodimer. Positive CD105 expression regulation was shown in tumour vasculature and proliferation cells, suggesting that it is a marker of proliferation-associated endothelial cells. CD105 is strongly expressed on endothelial cells and promotes 的angiogenesis during wound healing, infarction and in a wide range of tumours, its genetic expression is stimulated by hypoxia. CD105 binds to TGF beta 1 and 3 with a high affinity but not to TGF beta 2. Mutations of the CD105 gene cause hereditary haemorrhagic telangiectasia, also known as Osler-Rendu-Weber syndrome 1, a dominant autosomal multisystemic vascular dysplasia. Alternative splicing transcription variants that code different isoforms of CD105 have also been found. Diseases associated with CD105 dysfunction include inherited haemorrhagic telangiectasia.
Sensitivity
Sensitivity of dosage: 10 pg/ml.
Measurement range
Dosing range: 12.35 pg/ml to 3.000 pg/ml.
Duration of dosing
Total dosage duration: 4 hours 45 min.
Samples
Sample type: Plasma, Serum, Surnatant (plasma volume, 5 μl; serum, 5 μl; supernatant, 50 μl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17145429 |
| Specifications |
| Accession number | P17813 |
| Dose range | 12.35 pg/ml to 3.000 pg/ml |
| Sensitivity of the dosage | 10 pg/ml |
| Calibration range | 10 pg/ml to 3.000 pg/ml |
| Dose | ELISA solid-phase sandwich |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Protein family | Arterial morphogenesis; BMP signaling pathway; bone development; cell adhesion; cell chemotaxia; cell migration; cell migration involved in the formation of an endocardic cushion; cell motility; cellular response to mechanical stimuli; vasculogous |
| Type of sample | Plasma, Serum, Surnatant |
| Specificity | This ELISA kit shows no cross-reactivity with the following tested cytokines: human angiogenin, BDNF, BLC, ENA-78, FGF- 4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, G-CSF, GM-CSF, IFN-gamma, IL-12 p40, IL-13, IL-15, IL-309, IP-10, G-CSF, GM-CSF, IFN-gamma, |
| Sufficient for | 5 x 96 dosages |
| Target species | Human |
| For use with (application) | ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 2022 |
| Gene symbol(s) | END,HHT1,ORW1 |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | Standard, Stop Solution, SAV-HRP, Chromogen, Adhesive Plate Covers, Biotinylated Detection Antibody, Washing Stamp, 96-well pre-coated plates, Dosing Diluent Concentrate |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | RUO |
| Research disciplines | Extracellular Matrix & Cell Adhesion |
| Synonym | RP11-228B15.2, END, HHT1, ORW1 |
| Target | Human |
| Test time | 1 hour 20 minutes. |
| Physical characteristics |
| Volume of sample | Plasma, 5 μl; serum, 5 μl; supernatant, 50 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4:45 a.m. |
Origin and customs
| Manufacturer ref. | EHENGX5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.